MONICA FAZZINI: Open Payments
NPI 1720319189 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 28 payments from 9 companies in 2025. Trend: 2023 $275 · 2024 $459 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $243 |
| Janssen Biotech, Inc. | 3 | $79 |
| Aimmune Therapeutics, Inc. | 2 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Ardelyx, Inc. | 1 | $25 |
| COLOPLAST CORP | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: LINZESS, CREON, TREMFYA, ZENPEP, IQIRVO, RINVOQ, ENTYVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
